Back to search

Article

Impact of <sup>18</sup> FDG-avidity and immunosuppression on idiopathic and genetic cardiomyopathies

2026-02-03

Abstract excerpt

<h4>Background</h4> Myocardial 18 fluorodeoxyglucose ( 18 FDG)-avidity is frequently seen in patients with genetic cardiomyopathy (CMP), as well as a growing “idiopathic 18 FDG-avidity” group of genotype-negative patients who do not clearly have cardiac sarcoidosis (CS). <h4>Objectives</h4> To determine the prognostic implications of 18 FDG-avidity in patients with and without genetic CMP, and the effects o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cdbcdcd7-36a5-59d6-b7c4-a6db654040e2
DOI
10.64898/2026.01.30.26345250
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of <sup>18</sup> FDG-avidity and immunosuppression on idiopathic and genetic cardiomyopathiesDOI 10.64898/2026.01.30.26345250
Select a neighboring publication to make it the new centre.